介入放射學市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

2023 年，全球介入放射學市場估值為 281 億美元，預計 2024 年至 2032 年複合年成長率為 5%，原因是全球慢性病盛行率不斷上升，加上對微創手術的需求不斷增加。隨著癌症、心血管疾病和神經系統疾病等疾病變得越來越普遍，醫療保健提供者正在轉向介入放射學技術，這些技術可以提供有效的治療方案，縮短恢復時間並降低併發症的風險。這種向微創干預的轉變提高了患者的舒適度和滿意度，進一步推動介入放射學解決方案在臨床實踐中的採用。介入放射學產業根據產品、應用、最終用途和地區進行細分。

由於血管攝影系統在診斷和治療血管疾病方面發揮關鍵作用，因此到 2023 年將獲得 61 億美元的收入。這些先進的影像系統使醫療保健專業人員能夠即時觀察血管，有助於對動脈瘤和阻塞等疾病進行精確干預。心血管疾病的日益普及和對微創手術的需求正在推動血管攝影系統的採用。隨著技術不斷發展，提供改進的成像功能，該細分市場可能會保持其在市場上的主導地位。

由於全球心血管疾病盛行率不斷上升，心臟病學領域在 2023 年將佔據 31% 的佔有率。介入放射學技術，例如血管成形術和支架置入術，擴大用於心臟相關疾病的微創治療。隨著人們對心臟健康的認知不斷增強，越來越多的患者尋求先進的治療方案，對心臟病介入手術的需求正在激增。此外，影像技術和治療設備的不斷創新增強了這些干預措施的有效性，鞏固了心臟病學在市場上的領先地位。

北美介入放射學市場到 2023 年將達到 103 億美元，在先進的醫療基礎設施和高水準醫療技術投資的推動下，2024 年至 2032 年期間將以 4.3% 的複合年成長率成長。該地區對研究和開發的重視帶來了介入手術的重大創新，提高了患者的治療效果和手術效率。此外，人口老化的加劇和慢性病盛行率的增加也刺激了對介入放射服務的需求。由於高度重視病患照護和技術進步，北美將成為整體市場成長的核心貢獻者。

。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 全球慢性病盛行率上升
    • 成像技術的技術進步
    • 微創手術的需求不斷增加
    • 已開發國家老年人口基數不斷成長
  • 產業陷阱與挑戰
    • 與產品相關的高成本
    • 複雜的監管場景
• 成長潛力分析
• 監管環境
• 技術景觀
• 住院病人到門診病人的轉變型態
• 報銷場景
• 波特的分析
• PESTEL分析
• 未來市場趨勢
• 差距分析

第 4 章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

• 主要趨勢
• 血管攝影系統
• 超音波成像系統
• CT掃描儀
• 核磁共振系統
• 螢光透視系統
• 切片裝置
• 其他產品

第 6 章：市場估計與預測：按應用分類，2021 - 2032

• 主要趨勢
• 心臟病學
• 腫瘤學
• 婦科
• 產科
• 泌尿科
• 胃腸病學
• 其他應用

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

• 主要趨勢
• 醫院
• 診所
• 門診手術中心
• 其他最終用戶

第 8 章：市場估計與預測：按地區分類，2021 - 2032 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第 9 章：公司簡介

• Agfa-Gevaert Group
• Canon Medical Systems Corporation
• Carestream Health Inc.
• Cook
• Esaote SPA
• Fujifilm Corporation
• GE Healthcare
• Hologic, Inc.
• Koninklijke Philips N. V
• Olympus Corporation
• Samsung Healthcare (Samsung Electronics Co., Ltd.)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Shimadzu Corporation
• Siemens Healthineers
• Teleflex Incorporated

The Global Interventional Radiology Market was valued at USD 28.1 billion in 2023 and is projected to exhibit 5% CAGR from 2024 to 2032, driven by the rising prevalence of chronic diseases worldwide, coupled with an increasing demand for minimally invasive procedures. As conditions such as cancer, cardiovascular diseases, and neurological disorders become more common, healthcare providers are turning to interventional radiology techniques that offer effective treatment options with reduced recovery times and lower risk of complications. This shift towards less invasive interventions enhances patient comfort and satisfaction, further propelling the adoption of interventional radiology solutions in clinical practice. The interventional radiology industry is segmented based on product, application, end-use, and region.

The angiography systems segment garnered USD 6.1 billion in 2023 due to its critical role in diagnosing and treating vascular conditions. These advanced imaging systems enable healthcare professionals to visualize blood vessels in real-time, facilitating precise interventions for conditions such as aneurysms and blockages. The growing prevalence of cardiovascular diseases and the demand for minimally invasive procedures are boosting the adoption of angiography systems. As technology continues to evolve, offering improved imaging capabilities, this segment is likely to maintain its dominance in the market.

The cardiology segment held a 31% share in 2023, driven by the rising prevalence of cardiovascular diseases globally. Interventional radiology techniques, such as angioplasty and stenting, are increasingly utilized for minimally invasive treatment of heart-related conditions. As awareness of heart health grows and more patients seek advanced treatment options, the demand for interventional procedures in cardiology is surging. Besides, ongoing innovations in imaging technology and therapeutic devices enhance the effectiveness of these interventions, solidifying cardiology's leading position in the market.

North America interventional radiology market captured USD 10.3 billion in 2023 and will grow at a 4.3% CAGR between 2024 and 2032, fueled by advanced healthcare infrastructure and high levels of investment in medical technology. The region's emphasis on research and development has led to significant innovations in interventional procedures, enhancing patient outcomes and procedural efficiency. Additionally, a growing aging population and increasing prevalence of chronic diseases are fueling demand for interventional radiology services. With a strong focus on patient care and technological advancements, North America will emerge as a central contributor to the overall market growth.

.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of chronic disease worldwide
    • 3.2.1.2 Technological advancements in imaging technology
    • 3.2.1.3 Increasing demand for minimally invasive procedures
    • 3.2.1.4 Growing elderly population base in developed countries
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost associated with product
    • 3.2.2.2 Complex regulatory scenario
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 In-patient to outpatient shift landscape
• 3.7 Reimbursement scenario
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends
• 3.11 Gap analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Angiography systems
• 5.3 Ultrasound imaging systems
• 5.4 CT scanners
• 5.5 MRI systems
• 5.6 Fluoroscopy systems
• 5.7 Biopsy devices
• 5.8 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Cardiology
• 6.3 Oncology
• 6.4 Gynecology
• 6.5 Obstetrics
• 6.6 Urology
• 6.7 Gastroenterology
• 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Clinics
• 7.4 Ambulatory surgical centers
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Agfa-Gevaert Group
• 9.2 Canon Medical Systems Corporation
• 9.3 Carestream Health Inc.
• 9.4 Cook
• 9.5 Esaote SPA
• 9.6 Fujifilm Corporation
• 9.7 GE Healthcare
• 9.8 Hologic, Inc.
• 9.9 Koninklijke Philips N. V
• 9.10 Olympus Corporation
• 9.11 Samsung Healthcare (Samsung Electronics Co., Ltd.)
• 9.12 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 9.13 Shimadzu Corporation
• 9.14 Siemens Healthineers
• 9.15 Teleflex Incorporated